Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
- PMID: 9427614
- DOI: 10.1038/nm0198-097
Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
Abstract
Genetic causes of Alzheimer's disease (AD) include mutations in the amyloid precursor protein (APP), presenilin 1 (PS1), and presenilin 2 (PS2) genes. The mutant APP(K670N,M671L) transgenic line, Tg2576, shows markedly elevated amyloid beta-protein (A beta) levels at an early age and, by 9-12 months, develops extracellular AD-type A beta deposits in the cortex and hippocampus. Mutant PS1 transgenic mice do not show abnormal pathology, but do display subtly elevated levels of the highly amyloidogenic 42- or 43-amino acid peptide A beta42(43). Here we demonstrate that the doubly transgenic progeny from a cross between line Tg2576 and a mutant PS1M146L transgenic line develop large numbers of fibrillar A beta deposits in cerebral cortex and hippocampus far earlier than their singly transgenic Tg2576 littermates. In the period preceding overt A beta deposition, the doubly transgenic mice show a selective 41% increase in A beta42(43) in their brains. Thus, the development of AD-like pathology is substantially enhanced when a PS1 mutation, which causes a modest increase in A beta42(43), is introduced into Tg2576-derived mice. Remarkably, both doubly and singly transgenic mice showed reduced spontaneous alternation performance in a "Y" maze before substantial A beta deposition was apparent. This suggests that some aspects of the behavioral phenotype in these mice may be related to an event that precedes plaque formation.
Similar articles
-
Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.Exp Neurol. 2001 Aug;170(2):227-43. doi: 10.1006/exnr.2001.7710. Exp Neurol. 2001. PMID: 11476589
-
Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits.Behav Genet. 1999 May;29(3):177-85. doi: 10.1023/a:1021691918517. Behav Genet. 1999. PMID: 10547924
-
Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.Exp Neurol. 2001 Sep;171(1):59-71. doi: 10.1006/exnr.2001.7717. Exp Neurol. 2001. PMID: 11520121
-
Progress toward valid transgenic mouse models for Alzheimer's disease.Neurobiol Aging. 1999 Mar-Apr;20(2):201-11. doi: 10.1016/s0197-4580(99)00042-1. Neurobiol Aging. 1999. PMID: 10537029 Review.
-
Exploring the etiology of Alzheimer disease using molecular genetics.JAMA. 1997 Mar 12;277(10):825-31. JAMA. 1997. PMID: 9052714 Review.
Cited by
-
Translational Assays for Assessment of Cognition in Rodent Models of Alzheimer's Disease and Dementia.J Mol Neurosci. 2016 Nov;60(3):371-382. doi: 10.1007/s12031-016-0837-1. Epub 2016 Sep 16. J Mol Neurosci. 2016. PMID: 27637601 Review.
-
Alteration of Iron Concentration in Alzheimer's Disease as a Possible Diagnostic Biomarker Unveiling Ferroptosis.Int J Mol Sci. 2021 Apr 25;22(9):4479. doi: 10.3390/ijms22094479. Int J Mol Sci. 2021. PMID: 33923052 Free PMC article. Review.
-
Characterization of the role of the antioxidant proteins metallothioneins 1 and 2 in an animal model of Alzheimer's disease.Cell Mol Life Sci. 2012 Nov;69(21):3665-81. doi: 10.1007/s00018-012-1045-y. Epub 2012 Jul 6. Cell Mol Life Sci. 2012. PMID: 22766972 Free PMC article.
-
Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease.Alzheimers Res Ther. 2013 May 24;5(3):28. doi: 10.1186/alzrt182. eCollection 2013. Alzheimers Res Ther. 2013. PMID: 23705774 Free PMC article.
-
Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.J Neurosci. 2006 Oct 4;26(40):10129-40. doi: 10.1523/JNEUROSCI.1202-06.2006. J Neurosci. 2006. PMID: 17021169 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases